| Paula Kay Hubbard, | |
|
4200 Conestoga Dr, Springfield, IL 62711-7962 | |
| (217) 321-9323 | |
| Not Available |
| Full Name | Paula Kay Hubbard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 4200 Conestoga Dr, Springfield, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023517109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209017381 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Hospital | Decatur, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hshs Medical Group Inc | 5092857821 | 236 |
News Archive
A world leader in medical implants calls for a rethink in our approach to building medical implants.
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint.
According to Millennium Research Group, the global authority on medical technology market intelligence, the new reimbursement system from the Centers for Medicare & Medicaid Services for end stage renal disease will have a mixed but mostly negative effect on the market for ESRD treatment devices.
EXIRAD-3D, MILabs' new micron-resolution Single Photon Emission Computed Tomography (SPECT) technology, dedicated for imaging ex-vivo tissue samples is being launched by MILabs at the EANM congress in Barcelona.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 4 days ago
| Entity Name | Hshs Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962644807 PECOS PAC ID: 5092857821 Enrollment ID: O20100116000275 |
News Archive
A world leader in medical implants calls for a rethink in our approach to building medical implants.
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint.
According to Millennium Research Group, the global authority on medical technology market intelligence, the new reimbursement system from the Centers for Medicare & Medicaid Services for end stage renal disease will have a mixed but mostly negative effect on the market for ESRD treatment devices.
EXIRAD-3D, MILabs' new micron-resolution Single Photon Emission Computed Tomography (SPECT) technology, dedicated for imaging ex-vivo tissue samples is being launched by MILabs at the EANM congress in Barcelona.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula Kay Hubbard, 4200 Conestoga Dr, Springfield, IL 62711-7962 Ph: (217) 321-9323 | Paula Kay Hubbard, 4200 Conestoga Dr, Springfield, IL 62711-7962 Ph: (217) 321-9323 |
News Archive
A world leader in medical implants calls for a rethink in our approach to building medical implants.
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint.
According to Millennium Research Group, the global authority on medical technology market intelligence, the new reimbursement system from the Centers for Medicare & Medicaid Services for end stage renal disease will have a mixed but mostly negative effect on the market for ESRD treatment devices.
EXIRAD-3D, MILabs' new micron-resolution Single Photon Emission Computed Tomography (SPECT) technology, dedicated for imaging ex-vivo tissue samples is being launched by MILabs at the EANM congress in Barcelona.
Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.
› Verified 4 days ago
Alissa Danielle Smith, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3132 Old Jacksonville Rd, Suite 200, Springfield, IL 62704 Phone: 217-862-0800 | |
Lindsey Ostermeier, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3220 Atlanta St, Springfield, IL 62707 Phone: 217-588-7400 | |
Jessica L Lee, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 350 W Carpenter St, Springfield, IL 62702 Phone: 217-528-7541 Fax: 217-528-7144 | |
Mr. Jay Benoit, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 747 N Rutledge St Fl 5, Springfield, IL 62702 Phone: 217-545-8000 | |
Rebecca L Saunders, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 301 N 8th St, Pav 4b, Springfield, IL 62701 Phone: 217-545-7500 Fax: 217-545-7305 | |
Melanie R Reynolds, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3132 Old Jacksonville Rd, Suite 200, Springfield, IL 62704 Phone: 217-862-0730 Fax: 217-862-0822 | |
Amanda L. House, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1025 S 6th St, Springfield, IL 62703 Phone: 217-528-7541 |